Trial Details
UNKNOWNBasic Information
| Clinical ID | c1112 |
|---|---|
| Identifier | NCT04006080 |
| Trial Title | Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: Vedolizumab |
Participant Information
| Sponsor | Guy's and St Thomas' NHS Foundation Trust |
|---|---|
| City | London |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2019-07-01 |
|---|---|
| Primary Completion Date | 2025-03-20 |
| Completion Date | 2025-03-20 |